Lancashire and South Cumbria
Formulary
Formulary
2 Cardiovascular system
02-06-04 Peripheral vasodilators and related drugs
| Naftidrofuryl oxalate |
|
Formulary
|
Capsules 100mg |
 NICE TA223- Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease |
|
| Iloprost (IV) |
|
Formulary
|
Raynauds Specialist use only |
|
LSCMMG - Iloprost (IV) |
|
| Iloprost nebuliser solution |
|
Formulary
|
Pulmonary hypertension For use by specialist centres only. |
|
NHSE: high cost drugs commissioning list |
|
|
| Sildenafil |
|
Formulary
|
Tablets 25mg Digital ulceration Unlicensed indication - Specialist initiation only |
|
MHRA: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction NICE: Digital ulcers: sildenafil |
|
|
| Epoprostenol |
|
Formulary
|
Injection 500micrograms
|
|
MHRA: Veletri (epoprostenol) powder for solution for infusion: incompatibilities with some models of administration devices |
|
|
Restricted drug - specialist initiation only. 
Unlicensed use.| Cilostazol |
|
Formulary
|
|
NICE TA223- Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease |
|
Links
Enoxaparin Shared Care Guideline **FOR USE IN THE MORECAMBE BAY REGION ONLY**
Low Molecular Weight Heparins - Use in Primary care Best Practice Guideline *FOR USE IN PENNINE REGION ONLY* - LSC Statin Intolerance Pathway
- LSCMMG - Iloprost (IV)
- LSCMMG: Atrial Fibrillation Pathway for the prevention of stroke and systemic embolism in AF in the absence of valvular heart disease
- LSCMMG: Inclisiran for treating primary hypercholesterolaemia or mixed dyslipidaemia: Position Statement
- LSCMMG: Lipid Management Pathway for Primary Prevention of Cardiovascular Disease
- LSCMMG: Lipid Management Pathway for Secondary Prevention of Cardiovascular Disease
- LSCMMG: Low Molecular Weight Heparins (LMWHs) Summary Prescribing Guide
- MHRA Drug Safety Update Nov 18: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
- MHRA: Cilostazol (Pletal) - Risks of cardiovascular and bleeding events
- MHRA: Clopidogrel and proton pump inhibitors: interaction—updated advice
- MHRA: Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction
- MHRA: Veletri (epoprostenol) powder for solution for infusion: incompatibilities with some models of administration devices
- NG 185 - Acute coronary syndromes
- NG 196 - Atrial fibrillation: diagnosis and management
- NHSE: high cost drugs commissioning list
- NICE CG147: Lower limb peripheral arterial disease management
- NICE ESOUM42: Digital ulcers: sildenafil
- NICE NG106: Chronic heart failure in adults: diagnosis and management
- NICE NG136: Hypertension in adults: diagnosis and management
- NICE NG167: COVID-19 rapid guideline: rheumatological autoimmune, inflammatory and metabolic bone disorders
- NICE NG187: Acute heart failure: diagnosis and management
- NICE NG203: Chronic kidney disease: assessment and management
- NICE NG95: Recent-onset chest pain of suspected cardiac origin: assessment and diagnosis
- NICE TA223- Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
- NICE TA223- Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
- NICE TA223- Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
- NICE TA223: Intermittent claudication drugs
- NICE: Digital ulcers: sildenafil
- Renal: Enhanced Supportive Kidney Care Guideline